UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Sex Hormones and Anticancer Immunity

Clinical cancer research, 2019-08, Vol.25 (15), p.4603-4610

2019

Volltextzugriff (PDF)

Removing barriers to address sex differences in anticancer drug toxicity

Nature reviews. Cancer, 2024-03, Vol.24 (3), p.161

Özdemir, Berna C

2024

Volltextzugriff (PDF)

Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2680-2683

2018

Volltextzugriff (PDF)

Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors

Cancer treatment reviews, 2021-11, Vol.100, p.102282-102282, Article 102282

2021

Volltextzugriff (PDF)

Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology

Endocrinology (Philadelphia), 2022-06, Vol.163 (6), p.1

2022

Volltextzugriff (PDF)

Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e002220

Özdemir, Berna C

2021

Volltextzugriff (PDF)

The challenges of modeling hormone receptor-positive breast cancer in mice

Endocrine-related cancer, 2018-05, Vol.25 (5), p.R319-R330

2018

Volltextzugriff (PDF)

Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Trends in cancer, 2017-03, Vol.3 (3), p.181-197

2017

Volltextzugriff (PDF)

TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis

Journal of the American Society of Nephrology, 2013-03, Vol.24 (3), p.385-392

2013

Volltextzugriff (PDF)

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

The Journal of experimental medicine, 2021-02, Vol.218 (2)

2021

Volltextzugriff (PDF)

The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook

Pharmaceuticals (Basel, Switzerland), 2023-10, Vol.16 (10), p.1411

2023

Volltextzugriff (PDF)

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches

PloS one, 2014-12, Vol.9 (12), p.e114530-e114530

2014

Volltextzugriff (PDF)

Human epidermal growth factor receptor 2-positive digestive tumors

Current opinion in oncology, 2019-07, Vol.31 (4), p.354

2019

Volltextzugriff (PDF)

Successful treatment of immune checkpoint inhibitor-related periaortitis

Swiss medical weekly, 2024-02, Vol.154, p.3631

2024

Volltextzugriff (PDF)

Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis

Biology (Basel, Switzerland), 2022-03, Vol.11 (3), p.422

2022

Volltextzugriff (PDF)

Androgen Signaling in the Tumor Microenvironment

Advances in experimental medicine and biology, 2021, Vol.1270, p.169-183

2021

Volltextzugriff (PDF)

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.1991-2001

2023

Volltextzugriff (PDF)

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

iScience, 2023-04, Vol.26 (4), p.106212-106212, Article 106212

2023

Volltextzugriff (PDF)

The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (7), p.3847-3858

2023

Volltextzugriff (PDF)

Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology—a survey of Swiss clinicians

Cancer reports, 2024-02, Vol.7 (2), p.e1961-n/a

2024

Volltextzugriff (PDF)

Acute cardiac manifestations under immune checkpoint inhibitors—beware of the obvious: a case report

European heart journal : case reports, 2021-08, Vol.5 (8), p.ytab262

2021

Volltextzugriff (PDF)

Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort

European urology open science (Online), 2024-01, Vol.59, p.50-54

2024

Volltextzugriff (PDF)

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

European urology open science (Online), 2022-10, Vol.44, p.1-10

2022

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sex Hormones and Anticancer Immunity

Removing barriers to address sex differences in anticancer drug toxicity

Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology

Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology

The challenges of modeling hormone receptor-positive breast cancer in mice

Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches

Human epidermal growth factor receptor 2-positive digestive tumors

Successful treatment of immune checkpoint inhibitor-related periaortitis

Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis

Androgen Signaling in the Tumor Microenvironment

Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex

Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology—a survey of Swiss clinicians

Acute cardiac manifestations under immune checkpoint inhibitors—beware of the obvious: a case report

Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

Suchergebnisse filtern